Debra Zack - Mar 1, 2022 Form 4 Insider Report for EXAGEN INC. (XGN)

Role
Chief Medical Officer
Signature
/s/ Kamal Adawi, as attorney-in-fact
Stock symbol
XGN
Transactions as of
Mar 1, 2022
Transactions value $
-$23,076
Form type
4
Date filed
3/2/2022, 03:41 PM
Previous filing
Feb 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XGN Common Stock Tax liability -$23.1K -3.24K -3.7% $7.12 84.3K Mar 1, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were withheld from the Reporting Person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted on February 23, 2021.